Logo image of NPTN

NeoPhotonics Corporation (NPTN) Stock Fundamental Analysis

NYSE:NPTN - New York Stock Exchange, Inc. - US64051T1007 - Common Stock - Currency: USD

16.01  +0.01 (+0.06%)

After market: 16.01 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NPTN. NPTN was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. NPTN has a bad profitability rating. Also its financial health evaluation is rather negative. NPTN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NPTN had negative earnings in the past year.
NPTN Yearly Net Income VS EBIT VS OCF VS FCFNPTN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M 40M -40M -60M -80M

1.2 Ratios

Industry RankSector Rank
ROA -10.28%
ROE N/A
ROIC -8.46%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPTN Yearly ROA, ROE, ROICNPTN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 -5 -10 -15 -20 -25

1.3 Margins

Industry RankSector Rank
OM -7.62%
PM (TTM) -10.46%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NPTN Yearly Profit, Operating, Gross MarginsNPTN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 10 -10 20

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NPTN is destroying value.
NPTN has more shares outstanding than it did 1 year ago.
NPTN has a worse debt/assets ratio than last year.
NPTN Yearly Shares OutstandingNPTN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M
NPTN Yearly Total Debt VS Total AssetsNPTN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.22 indicates that NPTN is not a great score, but indicates only limited risk for bankruptcy at the moment.
A Debt/Equity ratio of 0.36 indicates that NPTN is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Altman-Z 2.22
ROIC/WACC-0.84
WACC10.11%
NPTN Yearly LT Debt VS Equity VS FCFNPTN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

NPTN has a Current Ratio of 2.57. This indicates that NPTN is financially healthy and has no problem in meeting its short term obligations.
A Quick Ratio of 1.95 indicates that NPTN should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.95
NPTN Yearly Current Assets VS Current LiabilitesNPTN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

NPTN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1050.00%.
The Revenue has decreased by -4.80% in the past year.
Measured over the past years, NPTN shows a decrease in Revenue. The Revenue has been decreasing by -6.74% on average per year.
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%

3.2 Future

Based on estimates for the next years, NPTN will show a very strong growth in Earnings Per Share. The EPS will grow by 72.02% on average per year.
NPTN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.89% yearly.
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NPTN Yearly Revenue VS EstimatesNPTN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NPTN Yearly EPS VS EstimatesNPTN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1 2

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NPTN. In the last year negative earnings were reported.
NPTN is valuated rather expensively with a Price/Forward Earnings ratio of 20.00.
NPTN's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 36.44.
Industry RankSector Rank
PE N/A
Fwd PE 20
NPTN Price Earnings VS Forward Price EarningsNPTN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -266.15
NPTN Per share dataNPTN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NPTN's earnings are expected to grow with 77.09% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.65%
EPS Next 3Y77.09%

More info and screens

0

5. Dividend

5.1 Amount

NPTN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NeoPhotonics Corporation

NYSE:NPTN (8/2/2022, 8:24:07 PM)

After market: 16.01 0 (0%)

16.01

+0.01 (+0.06%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-05 2022-08-05/amc
Earnings (Next)11-02 2022-11-02
Inst Owners1.01%
Inst Owner Change0%
Ins Owners18.64%
Ins Owner Change0%
Market Cap859.58M
Analysts74.55
Price Target15.81 (-1.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 20
P/S 2.7
P/FCF N/A
P/OCF N/A
P/B 5.67
P/tB N/A
EV/EBITDA -266.15
EPS(TTM)-0.23
EYN/A
EPS(NY)0.8
Fwd EY5%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.93
BVpS2.82
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.28%
ROE N/A
ROCE N/A
ROIC -8.46%
ROICexc N/A
ROICexgc -8.53%
OM -7.62%
PM (TTM) -10.46%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.98
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.57
Quick Ratio 1.95
Altman-Z 2.22
F-Score1
WACC10.11%
ROIC/WACC-0.84
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1050%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%126.67%
EPS Next Y169.52%
EPS Next 2Y97.65%
EPS Next 3Y77.09%
EPS Next 5Y72.02%
Revenue 1Y (TTM)-4.8%
Revenue growth 3Y-3.45%
Revenue growth 5Y-6.74%
Sales Q2Q%46.58%
Revenue Next Year26.78%
Revenue Next 2Y21.43%
Revenue Next 3Y20.67%
Revenue Next 5Y20.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A